Bharat Biotech's partner Ocugen seeks approval for Covaxin in Canada

The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults

Comments

Popular posts from this blog

BJP’s victory in local body polls indicator of coming Assembly polls: Bommai

Should there be a lesson on Jinnah?: Karnataka K.S. Eshwarappa asks

Bengaluru: Bus conductor fails to return Rs 1; court orders BMTC to pay Rs 3K as compensation